All individuals in LOINC
| Label | Id | Description |
|---|---|---|
| AIS Revision 1990 | LA21926-3 | |
| AIS Revision 1990 Update 1998 | LA21925-5 | |
| AIS Revision 2005 | LA21924-8 | |
| AIS Revision 2005 Update 2008 | LA21923-0 | |
| AIS Revision 2015 | LA21922-2 | |
| AJCC | LA4245-2 | |
| AJCC cancer staging manual | LP130436-1 | |
| AJCC cancer staging manual | MTHU041114 | |
| AJCC cancer staging manual:Find:Pt:^Patient:Nom:PhenX | 67203-0 | |
| AK | LA21992-5 | |
| AKB48 N-pentanoate | MTHU057399 | |
| AKB48 N-pentanoate (synthetic cannabinoid metabolite) | LP262532-7 | |
| AKB48 N-pentanoate (synthetic cannabinoid metabolite) | Urine | Drug toxicology | LP389562-2 | |
| AKB48 N-pentanoate:PrThr:Pt:Urine:Ord:Confirm | 87489-1 | |
| AKT1 gene | LP36214-2 | |
| AKT1 gene targeted mutation analysis | LP227570-1 | |
| AKT1 gene targeted mutation analysis | MTHU052142 | |
| AKT1 gene targeted mutation analysis | Blood or Tissue | Mutations | LP409347-4 | |
| AKT1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen | 42777-3 | |
| AL | LA21991-7 |